HEMATOPATHOLOGY ASSOCIATES LLC NPI 1164523478

NPI Details

HEMATOPATHOLOGY ASSOCIATES LLC is a clinical medical laboratory in St Petersburg, FL. The provider is (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology. HEMATOPATHOLOGY ASSOCIATES LLC NPI is 1164523478. The provider is registered as an organization entity type.
The provider Is Doing Business As Bio-genetics Laboratory.

The provider's business location address is:

805 EXECUTIVE CENTER DR W STE 300
ST PETERSBURG, FL
ZIP 33702-407
Phone: (727) 201-1890
Fax: (727) 275-1975

The provider's authorized official is Bryon Wolf .
The authorized official title is Owner and has the following contact phone number (727) 201-1890.

The CLIA number assigned to this NPI record is 10D1002586 - independent with a certificate type of Certificate of Accreditation.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Gene analysis (coagulation factor v) leiden variant (HCPCS:81241)
• Gene analysis (5, 10-methylenetetrahydrofolate reductase) common variants (HCPCS:81291)
• Gene analysis (cytochrome p450, family 2, subfamily d, polypeptide 6) common variants (HCPCS:81226)
• Gene analysis (prothrombin, coagulation factor ii) a variant (HCPCS:81240)
• Gene analysis (coagulation factor ix) full sequence analysis (HCPCS:81238)
• Gene analysis (bloom syndrome, recq helicase-like) (HCPCS:81209)
• Gene analysis (partner and localizer of brca2) full sequence analysis (HCPCS:81307)
• Gene analysis (phosphatase and tensin homolog), full sequence analysis (HCPCS:81321)
• Gene analysis (runt related transcription factor 1) targeted sequence analysis (HCPCS:81334)
• Gene analysis (cytochrome p450, family 2, subfamily c, polypeptide 19) common variants (HCPCS:81225)
• Gene analysis (adenomatous polyposis coli), full gene sequence (HCPCS:81201)
• Gene analysis (tumor protein 53) full sequence analysis (HCPCS:81351)
• Gene analysis (ccaat/enhancer binding protein [c/ebp], alpha) full gene sequence (HCPCS:81218)
• Gene analysis ((platelet-derived growth factor receptor, alpha polypeptide) targeted sequence (HCPCS:81314)
• Gene analysis (solute carrier organic anion transporter family, member 1b1) for common variant (HCPCS:81328)
• Gene analysis (cytochrome p450, family 2, subfamily c, polypeptide 9) common variants (HCPCS:81227)
• Gene analysis (telomerase reverse transcriptase) targeted sequence analysis (HCPCS:81345)
• Gene analysis (thiopurine s-methyltransferase) for common variant (HCPCS:81335)
• Gene analysis (neuroendocrine tumors), genomic sequence (HCPCS:81437)
• Gene analysis (v-kit hardy-zuckerman 4 feline sarcoma viral oncogene homolog), targeted sequence (HCPCS:81272)
• Gene analysis (breast cancer 1 and 2) of full sequence and analysis for duplication or deletion variants (HCPCS:81162)
• Gene analysis (nudix hydrolase 15) for common variants (HCPCS:81306)
• Gene analysis (fanconi anemia, complementation group c) common variant (HCPCS:81242)
• Gene analysis (phospholipase c gamma 2) for common variants (HCPCS:81320)
• Gene analysis (mpl proto-oncogene, thrombopoietin receptor) sequence analysis of exon 10 (HCPCS:81339)
• Gene analysis (janus kinase 2) targeted sequence analysis (HCPCS:81279)
• Gene analysis (myeloid differentiation primary response 88) for p.leu265pro variant (HCPCS:81305)
• Gene analysis for cancer (neuroblastoma) (HCPCS:81311)
• Gene analysis (glucose-6-phosphatase, catalytic subunit) common variants (HCPCS:81250)
• Gene analysis (cystic fibrosis transmembrane conductance regular) full gene sequence (HCPCS:81223)
• Gene analysis (glucose-6-phosphate dehydrogenase) full sequence analysis (HCPCS:81249)
• Gene analysis (postmeiotic segregation increased 2 [s cerevisiae]) full sequence analysis (HCPCS:81317)
• Gene analysis (muts homolog 6 [e coli]) full sequence analysis (HCPCS:81298)
• Gene analysis (mutl homolog 1, colon cancer, nonpolyposis type 2) full sequence analysis (HCPCS:81292)
• Gene analysis (muts homolog 2, colon cancer, nonpolyposis type 1) full sequence analysis (HCPCS:81295)
• Gene analysis (frataxin) of full sequence (HCPCS:81286)
• Gene analysis (noonan syndrome) genomic sequence analysis (HCPCS:81442)
• Test for detecting genes associated with heart disease, genomic sequence analysis panel, at least 9 genes (HCPCS:81410)
• Test for detecting genes associated with heart disease, duplication/deletion analysis panel (HCPCS:81411)
• Test for detecting genes associated with inherited disease of heart muscle (HCPCS:81439)
• Molecular pathology procedure level 2 (HCPCS:81401)
• Molecular pathology procedure level 5 (HCPCS:81404)
• Molecular pathology procedure level 6 genetic analysis (HCPCS:81405)
• Molecular pathology procedure level 7 (HCPCS:81406)
• Gene analysis (dihydropyrimidine dehydrogenase) for common variant (HCPCS:81232)
• Gene analysis (cytochrome p450 family 3 subfamily a member 5) for common variant (HCPCS:81231)
• Test for detecting genes associated with inherited breast cancer-related disorders (HCPCS:81432)
• Molecular pathology procedure level 4 (HCPCS:81403)
• Gene analysis (cytochrome p450 family 1, subfamily a, member 2) for common variants (HCPCS:0031U)
• Gene analysis (catechol-o-methyltransferase) for c.472g>a (rs4680) variant (HCPCS:0032U)
• Gene analysis (5-hydroxytryptamine receptor 2a) for common variants (HCPCS:0033U)
• Gene analysis (cytochrome p450 family 3 subfamily a member 4) for common variant (HCPCS:81230)
• Gene analysis (vitamin k epoxide reductase complex subunit 1) common variants (HCPCS:81355)

The enumeration date for this NPI number is 9/26/2006 and was last updated on 1/15/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: